Solid Biosciences Inc (NAS:SLDB)
$ 8.555 -0.565 (-6.2%) Market Cap: 328.14 Mil Enterprise Value: 169.77 Mil PE Ratio: 0 PB Ratio: 1.54 GF Score: 40/100

Solid Biosciences Inc at Barclays Global Healthcare Conference (Virtual) Transcript

Mar 11, 2021 / 02:45PM GMT
Release Date Price: $140.4 (-4.78%)
Huidong Wang
Barclays Bank PLC, Research Division - Research Analyst

Good morning, everyone. My name is Gena Wang. I'm senior biotech analyst at Barclays. Welcome to our second virtual Global Healthcare Conference. First, I wish everyone is staying healthy. And I would like to thank all the participants, investors, companies and especially our event team and corporate access team who made this virtual healthcare conference possible.

With that, I would like to introduce our next presenting company, Solid. With us, we have Joel Schneider, Chief Operating Officer. We also have Cathryn Clary, chief Medical Officer.

Joel, I will hand over to be you to begin you presentation.

Joel Solomon Zev Schneider
Solid Biosciences Inc. - COO

Thank you, Gena, and good morning, and I'll just share my slides very quickly.

Let's go to the beginning now. So good morning, Gena. Thank you for hosting us this morning. Just a quick recap for Solid and where we are before we dive into the fireside chat. 2021 is kicking off as an exciting year for us.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot